Alzheimer’s disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks. 

Pharmaceutical

Alzamend

Alzamend's headquarters in Salt Lake City, UT, United States

Stephan Jackman

James M. Turner

Kenneth S. Cragun

William B. Horne

Jeffrey Oram

Andrew H. Woo

Mark Gustafson

Henry C.W. Nisser

Lynne Fahey McGrath

Eric M. McDade

Thomas M. Wisniewski

Terri Hunter

The Scientific Advisors team at Alzamend provides expert guidance on the latest research and developments in Alzheimer’s disease treatment and prevention. They evaluate scientific data, advise on clinical trial design, and collaborate with researchers to ensure that innovative solutions align with the company’s mission to combat this progressive disorder. Their insights help shape strategic decisions and drive advancements in therapeutic approaches.

Scientific Advisors

The Leadership Team at Alzamend is responsible for guiding the company's strategic direction, overseeing operational execution, and ensuring fiscal health. Comprising key executives like the Chief Executive Officer and Chief Financial Officer, this team collaborates to drive innovative solutions in Alzheimer’s disease research and development, while fostering a culture of accountability and transparency within the organization.

Leadership Team

��

Alzamend

Org chart

Board & advisors

Teams

Scientific Advisors

Leadership Team

Offices

��������

Alzamend

Org chart

Board & advisors

Teams

Scientific Advisors

Leadership Team

Offices

Related companies

��